Fifty410 Tirzepatide Cost: Prepaid Dose Tiers vs Monthly Plans

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Fifty410 structures tirzepatide around three prepaid dose tiers: Starter ($399 for three months), Mid Dose ($499 for three months), and High Dose ($549 for three months). Each tier ships a full 12-week supply upfront; there is no monthly billing option. Over 12 months a patient cycles through four shipments, spending $1,596 to $2,196 depending on the tier prescribed. PlexusDx charges $289 month-to-month or $269/month on a three-month commitment—$3,228 over 12 months—but holds the same price at every tirzepatide dose. Fifty410's prepaid structure delivers a lower total cost if you can fund three months at a time and remain on a single tier; PlexusDx spreads the expense across 12 smaller transactions and never adjusts the rate when your clinician increases your dose.

Fifty410 tirzepatide plans at a glance

Fifty410 pricing captured September 4, 2026. Per-month equivalents and 12-month totals are our calculation assuming four three-month cycles. No membership fee; no contract. Compounded tirzepatide injections; not FDA-approved.

How Fifty410's prepaid dose-tier structure works

Fifty410 requires you to pay for three months of tirzepatide at once. The charge depends on the dose your clinician prescribes: Starter tier costs $399, Mid Dose $499, and High Dose $549. The full 12-week supply ships immediately after approval. If your provider increases your dose during the year, your next shipment moves to the corresponding tier and the upfront charge rises. Fifty410 does not offer a monthly billing cadence; every order is a three-month prepayment.

This structure lowers the effective monthly rate—$133 to $183 depending on tier—but demands liquidity every quarter. Patients who titrate upward will see costs step from $399 to $499 or $549 at their next refill. There is no membership fee, no contract, and Fifty410 states you pay only if a clinician writes the prescription.

Normalized 12-month cost comparison

Because Fifty410 bills quarterly and PlexusDx bills monthly, we normalize both to a 12-month window. Fifty410's total assumes four three-month cycles; PlexusDx totals reflect 12 monthly charges.

Twelve-month totals are our calculation. Fifty410 assumes four three-month cycles at a constant tier; stepping up to a higher tier increases cost proportionally. PlexusDx charges the same price at every tirzepatide dose.

Even PlexusDx's six-month commitment—the longest term available—totals $2,988, which sits between Fifty410's Mid and High Dose tiers over the same period. Fifty410's Starter tier saves $1,392 annually against PlexusDx's six-month plan and $1,632 against the month-to-month rate. The savings narrow or reverse if your clinician moves you from Starter to High Dose partway through the year.

Dose tiers vs. flat-rate pricing

Fifty410's three-tier system means your upfront charge rises when your clinician increases your dose. A patient who begins at the Starter tier ($399) and titrates to High Dose ($549) over the year will pay $399 + $499 + $549 + $549 = $1,996 for the first 12 months if they move up one tier per quarter. The tier labels—Starter, Mid, High—are Fifty410's own; the platform does not publish the exact milligram dose ranges that map to each tier on its pricing page.

PlexusDx holds $289 month-to-month, $269 on a three-month commitment, or $249 on a six-month commitment regardless of whether your provider writes 2.5 mg, 7.5 mg, or 15 mg. This flat-rate structure insulates your budget from dose adjustments but carries a higher nominal rate at every payment interval.

Liquidity and payment timing

Fifty410 asks for $399 minimum at checkout; PlexusDx's first charge is a single month ($289, $269, or $249 depending on commitment). Over three months the cash outlays are:

• Fifty410 Starter: $399 at month zero, $0 months one and two.
• PlexusDx month-to-month: $289 × 3 = $867 spread across three transactions.
• PlexusDx 3-month commitment: $269 × 3 = $807 spread across three transactions.

Fifty410's model reduces the total outflow but concentrates it; PlexusDx spreads the same or higher cost across smaller, predictable charges. If preserving monthly cash flow matters more than minimizing the annual total, the monthly rhythm may be preferable despite the higher 12-month sum.

What's included in each program

Both Fifty410 and PlexusDx bundle the clinician consultation, compounded tirzepatide medication, and shipping into the advertised price. Neither charges a membership fee. Fifty410 ships the full 12-week supply at once; PlexusDx ships monthly. Both programs state that payment occurs only if a licensed provider approves the prescription.

Service quality and patient experience

Fifty410 reports a 4.8-star rating across 5,891 Trustpilot reviews (provider's own claim on profile, captured September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Both programs show strong aggregate satisfaction; the volume of verified feedback for Fifty410 is substantially larger.

Choose Fifty410 if…

• You can comfortably fund three months of medication at once and prefer the lower effective monthly rate.
• You expect to remain on a stable dose tier for an extended period, avoiding mid-year tier increases.
• You value the convenience of receiving a full quarter's supply in a single shipment.
• The combined annual savings of $792 to $1,392 (Starter tier vs. PlexusDx six-month or month-to-month) justify the upfront payment cadence.

Choose PlexusDx if…

• You prefer to pay monthly rather than funding a full quarter at checkout, even if the 12-month total is higher.
• Dose-change predictability matters: your rate stays $289, $269, or $249 whether your clinician writes 2.5 mg or 15 mg.
• You want the flexibility to pause or adjust month-to-month without an outstanding prepaid balance.
• You value shipping every four weeks, aligning medication arrival with your injection schedule.

Medication availability and regulatory status

Both Fifty410 and PlexusDx dispense compounded tirzepatide injections. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Neither program guarantees medication availability; compounded supply depends on the FDA shortage list and pharmacy capacity. Confirm current availability at intake.

Methodology and freshness

Fifty410 pricing was captured from the provider's public pricing page on September 4, 2026. PlexusDx tirzepatide rates reflect the canonical pricing in effect as of September 13, 2026. We derived per-month equivalents for Fifty410's prepaid tiers by dividing the three-month upfront charge by three; these figures are labeled as our calculation throughout. Twelve-month totals assume four Fifty410 shipments at a constant tier and 12 monthly PlexusDx charges. Review ratings were captured from Trustpilot on September 4 and September 9, 2026. We did not apply promotional offers, referral credits, or insurance; all figures reflect advertised cash-pay rates. If you see different numbers at checkout, the provider may have updated terms after our capture date; confirm pricing before committing.

Frequently Asked Questions

Does Fifty410 offer a monthly payment option for tirzepatide?

No. Fifty410 structures all tirzepatide plans as prepaid three-month tiers. You pay $399, $499, or $549 upfront and receive a 12-week supply; there is no monthly billing cadence for tirzepatide.

What happens to my cost if my clinician increases my tirzepatide dose mid-year?

With Fifty410, your next three-month shipment moves to the corresponding higher tier—Mid Dose ($499) or High Dose ($549)—and your upfront charge rises accordingly. PlexusDx holds the same monthly rate ($289, $269, or $249 depending on your commitment) regardless of dose changes.

Are Fifty410's compounded tirzepatide injections FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

How much do I save over 12 months by choosing Fifty410's Starter tier instead of PlexusDx?

Fifty410's Starter tier totals $1,596 over 12 months (four $399 shipments). PlexusDx month-to-month costs $3,468 annually, so the Starter tier saves $1,872. Against PlexusDx's six-month commitment ($2,988/year), the Starter tier saves $1,392. These figures assume you remain on the Starter tier for the full year.

Can I switch from Fifty410 to PlexusDx or vice versa if my budget or dosing needs change?

Neither program guarantees a seamless transfer. You will complete a new intake, and the receiving clinician reviews your history independently. Medication availability, dose, and timing depend on that clinician's assessment and pharmacy stock. Neither provider can guarantee continuity from another platform.

Sources

• Fifty410 pricing page – captured September 4, 2026
• Fifty410 help-center terms – captured September 4, 2026
• PlexusDx tirzepatide injection product page – accessed September 13, 2026
• Trustpilot: Fifty410 profile – captured September 4, 2026
• Trustpilot: PlexusDx profile (trustpilot.com/review/plexusdx.com) – captured September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.